Pharmacology 3 - Protein Synthesis Inhibitors Part 2
82 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Aminoglycosides are used for the treatment of serious infections due to what type of bacilli?

  • anaerobic g-ve bacilli
  • aerobic g+ve bacilli
  • anaerobic g+ve bacilli
  • aerobic g-ve bacilli (correct)
  • The utility of aminoglycosides is limited by serious toxicities.

    True

    What is the structure of aminoglycosides?

    -two amino sugars joined by a glycosidic linkage to a central hexose nucleus

    Aminoglycosides are derived from:

    <p>either Streptomyces sp. (have -mycin suffixes) or Micromonospora sp. (end in -micin)</p> Signup and view all the answers

    What are the two hexose rings found in aminoglycoside structure?

    <p>streptodine and deoxystreptamine</p> Signup and view all the answers

    Which of the following is NOT an aminoglycoside?

    <p>Spectinomycin</p> Signup and view all the answers

    The drugs described in this chapter are bacteriostatic inhibitors of protein synthesis.

    <p>False</p> Signup and view all the answers

    How do aminoglycosides reach their target inside bacterial cells?

    <p>They diffuse through porin channels or are transported across the cytoplasmic membrane by an oxygen-dependent system.</p> Signup and view all the answers

    What is the primary site of action for aminoglycosides in bacterial cells?

    <p>30S ribosomal subunit</p> Signup and view all the answers

    In addition to interfering with the assembly of the ribosomal apparatus, how else do aminoglycosides disrupt protein synthesis?

    <p>They cause the 30S subunit of the completed ribosome to misread the genetic code.</p> Signup and view all the answers

    Aminoglycosides can inhibit protein synthesis in bacterial cells in at least three ways. Which of the following is NOT one of these ways?

    <p>Blocking the production of tRNA.</p> Signup and view all the answers

    Antibiotics that disrupt protein synthesis are generally bacteriostatic.

    <p>True</p> Signup and view all the answers

    Aminoglycosides are unique in being irreversible bactericidal.

    <p>True</p> Signup and view all the answers

    The bactericidal effect of aminoglycosides is NOT concentration-dependent.

    <p>False</p> Signup and view all the answers

    What is the target Cmax for aminoglycosides, compared to the MIC?

    <p>8X to 10X times the MIC.</p> Signup and view all the answers

    Aminoglycosides exhibit a post antibiotic effect (PAE) which is continued bacterial suppression after drug levels fall below the MIC

    <p>True</p> Signup and view all the answers

    Due to the PAE effect, aminoglycosides are best administered in divided daily doses.

    <p>False</p> Signup and view all the answers

    What is a potential drawback of administering a single large dose of aminoglycosides?

    <p>Increased risk of nephrotoxicity.</p> Signup and view all the answers

    Aminoglycosides are effective against a majority of aerobic g-ve bacilli, including multidrug-resistant strains.

    <p>True</p> Signup and view all the answers

    Aminoglycosides are best administered alone for treatment of infections.

    <p>False</p> Signup and view all the answers

    What is the specific example of synergistic effect that aminoglycosides are commonly used with?

    <p>In combination with a beta-lactam antibiotic to treat infective endocarditis, specifically Enterococcus faecalis and Enterococcus faecium.</p> Signup and view all the answers

    Low extracellular pH and anaerobic conditions enhance the transport of aminoglycosides across the bacterial cell membrane.

    <p>False</p> Signup and view all the answers

    What type of drugs can enhance the transport of aminoglycosides into bacterial cells?

    <p>Cell wall-active drugs like penicillin or vancomycin</p> Signup and view all the answers

    Tularemia is a rare lymphoid disease that can be effectively treated with gentamicin.

    <p>True</p> Signup and view all the answers

    Pseudomonas aeruginosa is a common cause of infection, easily affecting healthy individuals.

    <p>False</p> Signup and view all the answers

    Aminoglycosides are commonly used as monotherapy in the treatment of infections.

    <p>False</p> Signup and view all the answers

    Resistance to aminoglycosides can occur via:

    <p>All of the above</p> Signup and view all the answers

    Each of the enzymes involved in aminoglycoside resistance has its own specificity, meaning that cross-resistance can be presumed.

    <p>False</p> Signup and view all the answers

    Aminoglycosides are easily absorbed following oral administration.

    <p>False</p> Signup and view all the answers

    Which aminoglycoside is the exception to the rule of parenteral administration?

    <p>Neomycin</p> Signup and view all the answers

    What is the reason for Neomycin not being administered parenterally?

    <p>Severe nephrotoxicity.</p> Signup and view all the answers

    Neomycin is administered topically for skin infections and orally for bowel preparation prior to colorectal surgery.

    <p>True</p> Signup and view all the answers

    Once daily dosing of aminoglycosides is generally considered safe and effective, especially if creatinine clearance is > 60 mL/min.

    <p>True</p> Signup and view all the answers

    After intramuscular injection, what is the range of time for peak concentrations of aminoglycosides in the blood?

    <p>30-90 minutes</p> Signup and view all the answers

    Aminoglycosides are generally dosed based on actual body weight, regardless of body fat percentage.

    <p>False</p> Signup and view all the answers

    Aminoglycosides are highly hydrophilic, meaning they easily penetrate into most body fluids.

    <p>False</p> Signup and view all the answers

    Concentrations of aminoglycosides are often inadequate in the cerebrospinal fluid (CSF), even when the meninges are inflamed

    <p>True</p> Signup and view all the answers

    For central nervous system (CNS) infections, the intrathecal route of administration may be considered for aminoglycosides.

    <p>True</p> Signup and view all the answers

    Aminoglycosides do not readily cross the placental barrier.

    <p>False</p> Signup and view all the answers

    More than 90% of parenteral aminoglycosides are excreted unchanged in the urine.

    <p>True</p> Signup and view all the answers

    Aminoglycosides are commonly used in patients with renal dysfunction while maintaining the same dosage.

    <p>False</p> Signup and view all the answers

    Traditionally, aminoglycosides were given in two or three equally divided doses per day in patients with normal renal function.

    <p>True</p> Signup and view all the answers

    Administering the entire daily dose of aminoglycosides in a single injection is generally preferred in modern practice.

    <p>True</p> Signup and view all the answers

    Therapeutic drug monitoring of aminoglycoside plasma levels is not routinely performed.

    <p>False</p> Signup and view all the answers

    What is the primary purpose of therapeutic drug monitoring of aminoglycosides?

    <p>To ensure adequate dosing.</p> Signup and view all the answers

    Which adverse effect is most likely associated with aminoglycosides?

    <p>Ototoxicity</p> Signup and view all the answers

    Aminoglycoside-induced deafness is always reversible with appropriate treatment.

    <p>False</p> Signup and view all the answers

    Aminoglycoside ototoxicity is a risk for both adults and developing fetuses.

    <p>True</p> Signup and view all the answers

    Tobramycin has a higher risk of causing vestibular toxicity than gentamicin and streptomycin.

    <p>False</p> Signup and view all the answers

    Nephrotoxicity caused by aminoglycosides is always reversible with appropriate treatment.

    <p>False</p> Signup and view all the answers

    Individuals with renal insufficiency are at a decreased risk of developing nephrotoxicity from aminoglycosides.

    <p>False</p> Signup and view all the answers

    Concomitant use of aminoglycosides and loop diuretics is generally safe and poses no additional risk of toxicity.

    <p>False</p> Signup and view all the answers

    Which aminoglycoside is considered the most nephrotoxic?

    <p>Neomycin</p> Signup and view all the answers

    What is the most common allergic reaction to topically applied neomycin?

    <p>Contact dermatitis, which is an itchy rash.</p> Signup and view all the answers

    Neuromuscular paralysis, a side effect associated with aminoglycosides, is only a risk when the drug is administered in combination.

    <p>False</p> Signup and view all the answers

    Patients with myasthenia gravis are at a higher risk of developing neuromuscular paralysis when given aminoglycosides.

    <p>True</p> Signup and view all the answers

    Prompt administration of calcium gluconate or neostigmine can reverse the neuromuscular block caused by aminoglycosides.

    <p>True</p> Signup and view all the answers

    Aminoglycosides are recommended for use in patients with myasthenia gravis.

    <p>False</p> Signup and view all the answers

    Aminoglycosides easily penetrate into the central nervous system (CNS).

    <p>False</p> Signup and view all the answers

    Spectinomycin is an aminoglycoside antibiotic.

    <p>False</p> Signup and view all the answers

    Spectinomycin is mainly used for treating infections caused by Gram-negative bacteria.

    <p>True</p> Signup and view all the answers

    Spectinomycin is considered a first-line treatment for Gonorrhea.

    <p>False</p> Signup and view all the answers

    Aminoglycosides bind to the 30S site of ribosomal RNA, disrupting bacterial peptide elongation.

    <p>True</p> Signup and view all the answers

    Aminoglycosides are generally bactericidal against susceptible aerobic gram-negative bacteria.

    <p>True</p> Signup and view all the answers

    The antimicrobial activity of aminoglycosides is independent of pH.

    <p>False</p> Signup and view all the answers

    Gentamicin and Tobramycin are considered less effective than amikacin against Pseudomonas.

    <p>False</p> Signup and view all the answers

    Amikacin is typically chosen for treating infections caused by pathogens resistant to gentamicin and Tobramycin.

    <p>True</p> Signup and view all the answers

    Streptomycin has a broad range of applications in modern clinical practice.

    <p>False</p> Signup and view all the answers

    Aminoglycosides are more frequently used in combination with other antibiotics rather than on their own.

    <p>True</p> Signup and view all the answers

    Gentamicin is rarely used in combination therapy.

    <p>False</p> Signup and view all the answers

    Netilmicin shares many characteristics with gentamicin and tobramycin, including its effectiveness against gentamicin-resistant bacteria.

    <p>True</p> Signup and view all the answers

    Neomycin is considered ideal for treating infections due to its low toxicity and broad spectrum of activity.

    <p>False</p> Signup and view all the answers

    After oral administration, neomycin mainly acts by targeting the susceptible intestinal flora.

    <p>True</p> Signup and view all the answers

    Kanamycin, neomycin, and paromomycin all have similar properties; kanamycin is commonly used for multi-drug resistant tuberculosis.

    <p>True</p> Signup and view all the answers

    Paromomycin is considered to be effective against visceral leishmaniasis.

    <p>True</p> Signup and view all the answers

    Gentamicin is considered less effective against gram-positive bacteria compared to gram-negative bacteria.

    <p>False</p> Signup and view all the answers

    Gentamicin's effectiveness against susceptible bacteria is dependent on the concentration of the drug.

    <p>True</p> Signup and view all the answers

    Gentamicin's post-antibiotic effect, also known as PAE, is negligible.

    <p>False</p> Signup and view all the answers

    Spectinomycin is readily available in the USA.

    <p>False</p> Signup and view all the answers

    Tobramycin is more active than gentamicin against Pseudomonas aeruginosa.

    <p>True</p> Signup and view all the answers

    Tobramycin may have less nephrotoxic potential compared to gentamicin.

    <p>True</p> Signup and view all the answers

    Amikacin is resistant to many enzymes that inactivate gentamicin and tobramycin, making it a valuable option for treating infections caused by multidrug-resistant bacteria.

    <p>True</p> Signup and view all the answers

    Study Notes

    Pharmacology 3 - Protein Synthesis Inhibitors (Part 2)

    • Aminoglycosides are used to treat serious infections caused by aerobic gram-negative bacilli.
    • Their utility is limited by serious toxicities.
    • Structurally, aminoglycosides consist of two amino sugars linked to a central hexose nucleus via a glycosidic linkage.
    • They are derived from Streptomyces species (ending in "-mycin") or Micromonospora species (ending in "-micin").
    • Aminoglycoside structure includes a 1-hexose ring (streptidine in streptomycin) and a 2-hexose ring (deoxystreptamine in other aminoglycosides). Various amino sugars are attached via glycosidic linkages.
    • Examples of aminoglycoside agents include Streptomycin, Neomycin, Kanamycin, Amikacin, Gentamicin, Tobramycin, Sisomicin, Netilmicin, and Plazomicin, among others.
    • These drugs are bactericidal protein synthesis inhibitors that interfere with ribosomal function.
    • They diffuse through porin channels and are transported across the cytoplasmic membrane.
    • Inside the cell, they irreversibly bind to the 30S ribosomal subunit.
    • This binding interferes with ribosomal assembly and function.
    • The 30S subunit of the ribosome misreads the genetic code.
    • Aminoglycosides inhibit protein synthesis in at least three ways:
      • Interference with initiation complex formation.
      • Misreading of mRNA.
      • Breakup of polysomes into nonfunctional monosomes.
    • Antibiotics that disrupt protein synthesis are generally bacteriostatic. However, aminoglycosides are unique in their irreversible bactericidal action.
    • Bactericidal effect is concentration-dependent.
    • Dependent on Cmax (peak drug concentration) above MIC (minimum inhibitory concentration) of the target organism.
    • Aminoglycosides exhibit a post-antibiotic effect (PAE), which is continued bacterial suppression after drug levels fall below the MIC.
    • Single large doses given once daily are more common than divided daily doses, with the advantage of convenience but increasing the risk of nephrotoxicity.
    • Aminoglycosides are often combined with a β-lactam antibiotic for a synergistic effect, particularly in treating infective endocarditis of Enterococcus species.
    • Low extracellular pH and anaerobic conditions inhibit transport by reducing the gradient.
    • Transport can be enhanced by cell wall-active drugs (e.g., penicillin, vancomycin).
    • The major spectrum of activity is against aerobic gram-negative bacilli, often including multidrug-resistant species (e.g., Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species).
    • Resistance to aminoglycosides can occur through various mechanisms, including efflux pumps, altered uptake (porins), and enzymatic modification/inactivation of the drug. Cross-resistance isn't fully predictable due to the unique specificity of the enzymes.

    Pharmacokinetics

    • High polarity prevents adequate oral absorption.
    • All aminoglycosides (except neomycin) require parenteral administration for adequate serum levels.
    • Neomycin is administered topically or orally for bowel preparation prior to surgery due to its severe nephrotoxicity.
    • Peak concentrations in the blood, following intramuscular injection, reach their maximum between 30-90 minutes after administration.
    • Once-daily dosing is safe and effective if creatinine clearance is >60 mL/min (5-7 mg/kg gentamicin/tobramycin; 15 mg/kg amikacin).
    • Traditional dosing (divided doses) may be preferred for patients with lower creatinine clearance (<60 mL/min).

    Distribution

    • Aminoglycosides have similar pharmacokinetic properties.
    • Tissue concentrations can be subtherapeutic due to their hydrophilicity and variable penetration into body fluids.
    • Distribution into fatty tissue is low; dosing is based on lean body mass, not total body weight.
    • Concentrations in cerebrospinal fluid (CSF) are often inadequate, even in cases of inflamed meninges, necessitating intrathecal administration when indicated.
    • Aminoglycosides cross the placental barrier. They can accumulate in fetal plasma and amniotic fluid.

    Elimination

    • More than 90% of parenteral aminoglycosides are excreted unchanged in the urine.
    • Dose adjustments are required for those with renal dysfunction.
    • Traditional dosing involves equally divided doses daily for patients with normal renal function.
    • Single daily high-dose administrations are increasingly preferred when clinically indicated.

    Adverse Effects

    • Monitoring plasma levels is important (e.g., gentamicin, tobramycin, amikacin) to ensure adequacy and minimize dose-related toxicities.
    • Ototoxicity: Vestibular and auditory issues, including deafness (potentially irreversible). Vertigo is sometimes reported, particularly with streptomycin.
    • Nephrotoxicity: Includes mild reversible renal impairment to severe, potentially irreversible acute tubular necrosis. Elderly patients and those with renal impairment are particularly susceptible.
    • Concurrent Use with Other Nephrotoxic Agents: Concurrent use with loop diuretics (e.g., furosemide, ethacrynic acid) or other nephrotoxic antimicrobials (vancomycin, amphotericin B) can potentiate nephrotoxicity; concurrent use should be avoided. Neomycin, tobramycin, and gentamicin are the most nephrotoxic in this group.
    • Allergic Reactions: Contact dermatitis (rash) is a common reaction, particularly with topically applied neomycin.
    • Neuromuscular Paralysis: Associated with rapid increases in drug concentrations or concurrent administration with neuromuscular blocking agents. This is especially a risk factor to patients with myasthenia gravis. Using calcium gluconate or neostigmine (ACh-esterase inhibitor) can reverse the neuromuscular paralysis.

    Spectinomycin

    • Spectinomycin is an aminocyclitol antibiotic.
    • Structurally, it's related to the aminoglycosides group but lacks amino sugars and glycosidic bonds.
    • It's active in vitro against many gram-positive and gram-negative organisms.
    • Primarily used as an alternative treatment for drug-resistant gonorrhea or penicillin-allergic patients.

    Clinical Uses

    • Aminoglycosides are typically used against gram-negative enteric bacteria.
    • This includes situations when the isolate is drug-resistant or if there is suspicion of sepsis.
    • They are often combined with β-lactam antibiotics to extend coverage to include gram-positive pathogens, and take advantage of a synergistic effect.
    • Frequently used in combination therapy, particularly with gentamicin for empiric therapy.
    • For certain infections and specific pathogens (e.g., Pseudomonas, Klebsiella), different aminoglycosides may be preferred based on efficacy and/or reduced toxicity.
    • Monotherapy with aminoglycosides is occasionally indicated (e.g., tularemia and plague).

    Empiric Use

    • Aminoglycosides are often used initially as empiric therapy in combination with other antibacterial agents to cover a wide range of potential pathogens.
    • Once the pathogen is identified and sensitivities determined, a less toxic antibiotic can be substituted to complete the treatment course.

    Netilmicin, Neomycin and Others

    • Netilmicin shares characteristics with gentamicin and tobramycin and may be efficacious against some resistant strains.
    • Neomycin is generally limited to topical or oral use due to toxicity associated with parenteral use and higher resistance in enteric flora after oral administration.
    • Neomycin, kanamycin, and paromomycin have similar pharmacologic properties. Kanamycin's clinical uses are limited to treating multi-drug-resistant tuberculosis; paromomycin shows efficacy against visceral leishmaniasis.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz focuses on aminoglycosides, a class of protein synthesis inhibitors used to treat serious infections. You will learn about their structure, mechanism of action, examples, and associated toxicities. Prepare to test your knowledge on this essential pharmacological topic!

    More Like This

    Use Quizgecko on...
    Browser
    Browser